http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101575170-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate | 2012-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101575170-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating muscle weakness diseases comprising Tetramizole |
| abstract | The present invention relates to a composition for promoting the differentiation of myoblasts comprising tetramisole or a pharmaceutically acceptable salt thereof, a composition for promoting the differentiation of myoblasts, comprising a step of treating extracorporeal cells with tetramisole or a pharmaceutically acceptable salt thereof, A method for promoting the differentiation of tetracycline or tetracycline or a pharmaceutically acceptable salt thereof, and a method for producing differentiated myocytes comprising the step of treating the extracellular source cells to differentiate the source cells, The present invention relates to a pharmaceutical composition for preventing or treating muscular weakening-related diseases and a food composition for preventing or ameliorating muscular weakness-related diseases. The tetramisole according to the present invention can promote root differentiation and root canal formation, thereby preventing muscle weakness and effectively improving muscle function. Accordingly, the pharmaceutical composition containing the same can be usefully used for the prevention or treatment of muscular weakening-related diseases. |
| priorityDate | 2012-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.